H istone deacetylase complexes (HDACs) are powerful regulators of the epigenome. It is now clear that a subset of HDACs also regulate the stability of the genome itself, but not primarily through transcription. Instead, these key HDACs control genome stability more directly by stabilizing enzymes important for DNA mutagenesis and repair, or by modifying histones at sites of DNA damage. Surprisingly, certain HDACs in budding yeast and human cells accelerate the pace of genetic expansions in trinucleotide repeats, the type of mutation that causes Huntington disease. In other words, HDACs promote mutagenesis in some settings. At double-strand breaks, however, the same HDACs in budding yeast help stabilize the genome by facilitating homology-dependent repair. Double-strand breaks can also be repaired without the requirement for homology, and two specific human HDACs are now known to promote this event. These new findings highlight certain HDACs as caretakers of genome stability, and also underscore the potential medical complexities in using HDAC inhibitors for treatment of disease.
the norm, not the exception, in affected families. Furthermore, high expansion frequencies led to the inference that cellular proteins actually promote (favor) expansions, 5 despite the detrimental effects of these mutations. These proteins generally protect genome stability, but it is thought that the TNR DNA "corrupts" their normal activities, leading inadvertently to expansions. 1, 3, 6 Transgenic mice with long TNRs also display extremely high expansion rates, which allowed the identification of several DNA repair proteins as promoting factors, based on the fact there are fewer expansions in mice lacking these repair proteins. [7] [8] [9] [10] [11] [12] [13] [14] These findings are consistent with misrepair of DNA as a source of TNR expansions.
We recently reported that specific HDACs are novel promoting factors for TNR expansions in budding yeast and human cells. 15 In other words, HDACs are causal in the mutational process of going from short to expanded repeats. Thus, HDACs join DNA repair proteins as promoting factors for TNR expansions. It is important to distinguish this finding from what is already known about differences in chromatin structure for normallength and expanded TNRs, where the latter tend be in a more heterochromatic environment. 16 Differences in chromatin structure are especially important for diseases like fragile X syndrome and Friedreich's ataxia, where gene silencing is an important feature leading to disease.
SUMOylation of proteins). In the caretaker model, yeast Sae2 represents an expansion promoting protein (Fig. 2B) . Sae2 is stabilized by deacetylation in an Rpd3-and Hda1-dependent manner, so in mutants lacking these HDACs, Sae2 is degraded. 25 As predicted by the caretaker model, mutants deficient in Sae2 or the related nuclease Mre11 also gave lower expansion rates, and double mutant analysis supported a pathway involving both Rpd3 and Mre11 (Fig. 2B) . 15 It is likely that Rpd3L and Hda1 target other proteins besides Sae2 that promote expansions in budding yeast, as loss of Sae2 gave a milder expansion phenotype than HDAC defects. Importantly, the mechanism in human cells-either gatekeeper or caretaker-awaits elucidation.
How might Sae2 provoke expansions? Sae2 is most often thought of as an endprocessing enzyme required for efficient repair of DNA double-strand breaks (detailed in the next section). However, expansions of short TNRs do not require other double-strand break repair proteins like Rad51 and Rad52. 26, 27 This distinction led to the suggestion that TNR hairpins, not double-strand breaks, are the relevant targets of Sae2 and Mre11 in our experimental system. 15 By this model, TNR hairpin processing requires Sae2 and Mre11 but cleavage does not lead to, or result from, a double-strand break. This idea is supported by the observations that Sae2 and Mre11 process DNA hairpins both in vivo and in vitro, 28, 29 and that virtually all models of TNR expansions envision a mutagenic intermediate comprised of a hairpin or other aberrant DNA structure. [1] [2] [3] However, it remains to be proven that Sae2 and Mre11 actually process a TNR hairpin to promote expansions.
Double-Strand Break Repair
DNA double-strand breaks (DSBs) are one of the most serious types of DNA damage. Eukaryotic cells repair DSBs in two ways, one that is homology-dependent and a second process called non-homologous end joining (NHEJ). Both pathways rejoin the break and therefore stabilize the chromosome, although NHEJ often entails gains or losses of nucleotides at the break site and is therefore somewhat mutagenic. It is well human cells (Fig. 1A) , thus stabilizing these repeating DNA elements.
HDACs do not have the enzymatic capacity to alter DNA lengths, so it was clear that there must be downstream targets. Two types of models were tested in budding yeast for HDAC effects on triplet repeat expansions (Fig. 2) . 15 A "gatekeeper" hypothesis posits that Rpd3L and Hda1 modify histones near the TNR and thereby regulate access of the proteins that actually expand the DNA ( Fig. 2A) . The gatekeeper would therefore exert its influence locally. To test this idea, the TNR reporter was integrated into two types of genomic location. In "hot" zones, transcript levels 21, 22 and histone acetylation 23, 24 are exceedingly sensitive to the presence or absence of Rpd3. "Cold" zones, where message levels and histone acetylation are indifferent to Rpd3 status, were also tested. Surprisingly, there were no changes in either expansion rates or histone H4 pan-acetylation near the TNR regardless of whether the triplet repeat was integrated at hot or cold zones. 15 In budding yeast, the gatekeeper model is not supported by the available data. Instead, the results are better explained by a caretaker model (Fig. 2B) , where HDACs influence proteins or genes at a distance, which then travel to the TNR to exert their effects. Although transcriptional regulation is the most obvious caretaker mechanism, the data instead support HDAC stabilization of the non-histone protein Sae2, a nuclease. (Budding yeast Sae2 nuclease is unrelated to the human enzyme SAE2, which activates SUMO for post-translational TNR promoting factors (Fig. 1A) . 15 This blind screen identified several subunits of Rpd3L and Hda1 at a frequency about 100-fold higher than random chance. Subsequent genetic analysis with targeted knockouts of Rpd3L or Hda1 showed suppression of expansion rates by up to 90%. In double mutants lacking both HDACs, the expansion phenotype was even more pronounced. Treatment of wild type yeast with the HDAC inhibitor TSA also suppressed expansions. This analysis in budding yeast indicated that both the class I enzyme Rpd3L and the class II prototype Hda1 19 promote TNR expansions.
Using a human astrocytic cell line, we showed that the class I enzyme HDAC3 also promotes expansions. 15 Knockdown with siRNA or treatment with an HDAC3-selective inhibitor blocked about 75% of expansions (Fig. 1A) . In contrast, knockdown or inhibition of HDAC1 did not suppress expansions. The involvement of HDACs in promoting expansions is consistent with an earlier report in Drosophila, where treatment of flies with TSA reduced expansion frequencies. 20 The Drosophila work also identified CBP as a histone acetyltransferase (HAT) with the contravening effect. CBP stabilized TNRs, based on the observation that CBP haploinsufficient animals displayed elevated expansion frequencies. 20 We knocked down human CBP, the related HAT p300, or both and saw increased frequencies of expansions in cultured astrocytes. 15 CBP and p300 are now implicated as factors that inhibit expansions in so caution must be used to avoid oversimplifying the picture. Two gatekeepertype models (similar to Fig. 2A) were put forth. 31 HDAC1 and HDAC2 may affect the ability of NHEJ factors to access DSBs or to function effectively there. Alternatively, HDAC1 and HDAC2 may act to repress transcription at sites of DNA damage, thus preventing transcription from interfering with repair. A partial contribution of a caretaker model, based on direct targeting of NHEJ factors by the HDACs, could not be ruled out, however.
Concluding Remarks
There are several surprises in the work summarized above. The first is that certain HDACs help cause mutagenesis at trinucleotide repeats. A second surprise is the specificity of the relevant HDACs. There are 18 known human HDACs 19, 34 but only a few were shown to be important for NHEJ 31 or TNR expansions. 15 Third, HDACs serve as both caretakers and gatekeepers during DNA mutagenesis and repair by targeting both non-histone proteins and histones. Together, these findings underscore the importance of HDACs on genome stability. Along with these new insights come unexpected challenges. In terms of mechanism, the multifaceted functions of HDACs make it difficult to tease out all the ways they regulate control DNA mutagenesis and repair. Gene expression, although the relevant HDACs is SIRT6, 32 a class III enzyme. Nevertheless, it is now clear that Rpd3 and Hda1 are caretakers during homology-dependent repair of DSBs, helping avoid mutation by stabilizing key nucleases and allowing these enzymes to perform their important repair functions. 25 This is similar to the caretaker model shown in Figure 2B . In fact, the rationale for testing Sae2 in TNR expansions was inspired by the findings of Robert et al. 25 Non-homologous end joining is also regulated by specific HDACs, as highlighted in a recent publication from the laboratory of Steve Jackson. 31 NHEJ usually requires minimal processing of the DSB, occurs rapidly, and uses a discrete set of proteins, all of which set NHEJ apart from homology-dependent repair. 33 Miller et al. showed that HDAC1 and HDAC2 are the key HDACs in promoting NHEJ (Fig. 1B) . 31 HDAC1 and HDAC2 were rapidly recruited to sites of DNA damage induced by several agents that cause DSBs. Depletion of HDAC1 and HDAC2 caused cell hypersensitivity to DNA damaging agents and a sustained DNA damage response, consistent with reduced levels of NHEJ. HDAC1 and HDAC2 were important for globally deacetylating histones at H3K56 and H4K16, with the former modification also perturbed at sites of DNA damage. The authors note that depletion of HDAC1 and HDAC2 likely cause additional defects besides NHEJ, 31 known that HDACs and HATs are among the many factors recruited to DSBs. 30 In most cases, it was thought that HDACs act primarily as gatekeepers, helping to selectively recruit proteins to the DSB for repair and damage signaling. 30 Two recent studies provide a better understanding for how HDACs modulate DSB repair. In one case, specific HDACs act as caretakers, 25 whereas the second paper helps clarify a gatekeeper function by distinct HDACs. 31 The laboratory of Marco Foiani discovered that the budding yeast HDACs Rpd3 and Hda1 link processing of DSBs with the DNA damage response and autophagy. 25 Inhibition of Rpd3 and Hda1 or mutation of the genes encoding them resulted in inability to process the DSB for homology-dependent repair and also in poor activation of the DNA damage response. Thus, Rpd3 and Hda1 favor homology-dependent repair (Fig. 1B) . The relevant target of Rpd3 and Hda1 in this case was not histones, but rather the nucleases Sae2 and ExoI, which are necessary for processing of the broken chromosome ends. Yeast Sae2 and ExoI are deacetylated in an Rpd3-and Hda1-dependent manner, although it is not clear yet whether this deacetylation is direct. Deacetylation of the nucleases protects them from degradation via autophagy. The counteracting HAT is Gcn5, which acetylates Sae2 and ExoI (Fig. 1B) . The mammalian form of Sae2, called CtIP, is also deacetylated to promote end processing, chromatin structure, and the firing of DNA replication origins are just some of the additional considerations that must be included in thinking about HDACs and the genome. [35] [36] [37] [38] [39] With respect to medicine, the use of HDAC inhibitors (HDACi) as potential therapies has great promise, 40, 41 but only now are we beginning to understand the ramifications of these inhibitors and their possible side effects on genomic stability. For example, using HDACi to sensitize tumors to radiation could lead to secondary mutations. 31, 42 On the other hand, using HDACi to offset the transcriptional defects in Huntington disease 43 may have the additional benefit of reducing somatic expansions at the HD gene and thereby slowing disease progression. 15 For HDACi therapy to be optimally beneficial, it is crucial that specific HDACs continue to be identified in relevant disease-related pathways, and that isotypeselective inhibitors be further developed for more precise targeting.
